HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Antimicrobial development in the era of emerging resistance.

Abstract
Antibiotics currently under study by the Food and Drugs Administration include: faropenem (for treatment of sinusitis, bronchitis, and community-acquired pneumonia), dalbavancin (for catheter infections), telavancin (for treatment of nosocomial pneumonia), oritavancin (for bacteremia), ceftobiprole and iclaprim (for pneumonias). Moreover, all of them would be useful for skin and soft tissue infections.
AuthorsAntonio Sorlozano, Cristina Carrasco, Jose Cabeza, Enrique Villegas, Jose Gutierrez
JournalMini reviews in medicinal chemistry (Mini Rev Med Chem) Vol. 9 Issue 8 Pg. 938-55 (Jul 2009) ISSN: 1389-5575 [Print] Netherlands
PMID19601889 (Publication Type: Journal Article)
Chemical References
  • Aminoglycosides
  • Anti-Bacterial Agents
  • Cephalosporins
  • Glycopeptides
  • Pyrimidines
  • beta-Lactams
  • iclaprim
  • ceftobiprole
  • Teicoplanin
  • dalbavancin
  • fropenem
  • oritavancin
  • telavancin
Topics
  • Aminoglycosides (adverse effects, chemistry, pharmacology, therapeutic use)
  • Animals
  • Anti-Bacterial Agents (adverse effects, chemistry, pharmacology, therapeutic use)
  • Bacteria (drug effects)
  • Cephalosporins (adverse effects, chemistry, pharmacology, therapeutic use)
  • Drug Approval
  • Drug Resistance, Bacterial
  • Glycopeptides (adverse effects, chemistry, pharmacology, therapeutic use)
  • Humans
  • Pyrimidines (adverse effects, chemistry, pharmacology, therapeutic use)
  • Skin Diseases, Bacterial (drug therapy)
  • Skin Diseases, Viral (drug therapy)
  • Teicoplanin (adverse effects, analogs & derivatives, chemistry, pharmacology, therapeutic use)
  • United States
  • United States Food and Drug Administration
  • beta-Lactams (adverse effects, chemistry, pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: